Hyperliquid's Major Financial Report Released: Nasdaq Listing, HYPE Token, and Stock Buyback Combined
Hyperliquid Strategies Inc. announced quarterly financial performance for the period ending December 31, 2025, key highlights:
On December 2, 2025, officially listed on Nasdaq through a merger with Sonnet BioTherapeutics Holdings, Inc.
Establishing a strong initial capital pool:
12.5 million HYPE tokens
Investors injected $300 million in cash
